1, 25‐dihydroxyvitamin D3‐induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells. Issue 3 (10th July 2017)
- Record Type:
- Journal Article
- Title:
- 1, 25‐dihydroxyvitamin D3‐induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells. Issue 3 (10th July 2017)
- Main Title:
- 1, 25‐dihydroxyvitamin D3‐induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells
- Authors:
- Xie, Zhongxiang
Chen, Jingtao
Zheng, Chao
Wu, Jing
Cheng, Yun
Zhu, Shan
Lin, Chenhong
Cao, Qingqing
Zhu, Jie
Jin, Tao - Abstract:
- Summary: Dendritic cells (DCs), a bridge for innate and adaptive immune responses, play a key role in the development of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), an animal model for MS. Administration of tolerogenic DCs has been used as an immunotherapy in autoimmune diseases. Deficiency of vitamin D is an environmental risk factor of MS. In this study, we induced tolerogenic DCs by 1, 25‐dihydroxyvitamin D3 and transferred the tolerogenic DCs (VD3 ‐DCs) into EAE mice by adoptive transfer. We found that VD3 ‐DCs inhibited the infiltrations of T helper type 1 (Th1) and Th17 cells into spinal cord and increased the proportions of regulatory T cells (CD4 + CD25 + Foxp3 + ), CD4 + IL‐10 + T cells and regulatory B cells (CD19 + CD5 + CD1d + ) in peripheral immune organs, which resulted in attenuated EAE. However, the proportions of T helper type 1 (Th1) and Th17 cells in spleen and lymph nodes and the levels of pro‐inflammatory cytokines and IgG in serum also increased after transfer of VD3 ‐DCs. We conclude that transfer of VD3 ‐DCs suppressed EAE by increasing proportions of regulatory T cells, CD4 + IL‐10 + T cells and regulatory B cells in spleen and reducing infiltration of Th1 and Th17 cells into spinal cord, which suggests a possible immunotherapy method using VD3 ‐DCs in MS. Abstract : 1, 25‐Dihydroxyvitamin D3 induced tolerogenic DCs (VD3 ‐DCs) showed a similar characterization with tolerogenic DCs. Adoptive transfer of VD3 ‐DCsSummary: Dendritic cells (DCs), a bridge for innate and adaptive immune responses, play a key role in the development of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), an animal model for MS. Administration of tolerogenic DCs has been used as an immunotherapy in autoimmune diseases. Deficiency of vitamin D is an environmental risk factor of MS. In this study, we induced tolerogenic DCs by 1, 25‐dihydroxyvitamin D3 and transferred the tolerogenic DCs (VD3 ‐DCs) into EAE mice by adoptive transfer. We found that VD3 ‐DCs inhibited the infiltrations of T helper type 1 (Th1) and Th17 cells into spinal cord and increased the proportions of regulatory T cells (CD4 + CD25 + Foxp3 + ), CD4 + IL‐10 + T cells and regulatory B cells (CD19 + CD5 + CD1d + ) in peripheral immune organs, which resulted in attenuated EAE. However, the proportions of T helper type 1 (Th1) and Th17 cells in spleen and lymph nodes and the levels of pro‐inflammatory cytokines and IgG in serum also increased after transfer of VD3 ‐DCs. We conclude that transfer of VD3 ‐DCs suppressed EAE by increasing proportions of regulatory T cells, CD4 + IL‐10 + T cells and regulatory B cells in spleen and reducing infiltration of Th1 and Th17 cells into spinal cord, which suggests a possible immunotherapy method using VD3 ‐DCs in MS. Abstract : 1, 25‐Dihydroxyvitamin D3 induced tolerogenic DCs (VD3 ‐DCs) showed a similar characterization with tolerogenic DCs. Adoptive transfer of VD3 ‐DCs suppressed experimental autoimmune encephalomyelitis by increasing proportions of regulatory T cells, CD4 + IL‐10 + T cells and regulatory B cells in spleen and reducing infiltration of Th1 and Th17 cells into spinal cord. … (more)
- Is Part Of:
- Immunology. Volume 152:Issue 3(2017)
- Journal:
- Immunology
- Issue:
- Volume 152:Issue 3(2017)
- Issue Display:
- Volume 152, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 152
- Issue:
- 3
- Issue Sort Value:
- 2017-0152-0003-0000
- Page Start:
- 414
- Page End:
- 424
- Publication Date:
- 2017-07-10
- Subjects:
- 1, 25‐dihydroxyvitamin D3 -- experimental autoimmune encephalomyelitis -- multiple sclerosis -- tolerogenic dendritic cells
Immunology -- Periodicals - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2567 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=imm&close=1997#C1997 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/imm.12776 ↗
- Languages:
- English
- ISSNs:
- 0019-2805
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4369.700000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4747.xml